Skip to main content
Premium Trial:

Request an Annual Quote

FDA to Integrate IMMD s KeyMolnet with ArrayTrack to Review Data

NEW YORK, Nov. 21 (GenomeWeb News) - The US Food and Drug Administration will integrate its ArrayTrack tool with KeyMolnet, the Institute of Medicinal Molecular Design said Friday.


Integrating ArrayTrack and KeyMolnet allows FDA scientists to study drug efficacy and toxicity from pharmacogenomic data submissions.


Tokyo-based IMMD's KeyMolnet is a next-generation bioinformatics platform for scientists to examine the relationship between genes, molecules, pathways, and drugs through multi-dimensional perspectives. ArrayTrack is a microarray data-management, -analysis, and -interpretation system.


Financial details were not disclosed.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.